✍️ RxDiff Savings Team | Reviewed by Thomas Tang, PharmD | Last reviewed: July 2026
GLP-1 Manufacturer Coupon Comparison 2026: Wegovy, Zepbound, Ozempic & Mounjaro Pricing
GLP-1 medications have transformed weight loss treatment — but their pricing remains one of the biggest barriers for patients. List prices for brand-name GLP-1 weight loss drugs like Wegovy and Zepbound exceed $1,000 per month without insurance, making manufacturer savings cards and alternative options essential for most patients.
This guide compares GLP-1 medication pricing in 2026 across all major brands, breaks down manufacturer savings programs, and explains every option available for getting weight loss medications without insurance. Use RxDiff to compare current GLP-1 prices at pharmacies near you.
GLP-1 Medication Pricing in 2026: The Full Picture
GLP-1 medication cost in 2026 ranges from roughly $299–$1,400 per month at list price depending on the drug and dose. It and It are the two primary FDA-approved injectable GLP-1 losing weight medications. Ozempic and Mounjaro are approved for type 2 diabetes but widely prescribed off-label for weight management. All four have manufacturer savings cards that significantly reduce monthly cost for commercially insured patients.
TTThe list price for This glp-1, The medication, Ozempic, and Mounjaro reflects Novo Nordisk and Eli Lilly's prices strategies — but what you actually pay depends heavily on your insurance coverage, which manufacturer savings card you qualify for, and whether compounded versions are available through your GLP-1 provider.
"table-wrap">
| Medication | List Price/Mo | With Savings Card |
|---|
| Wegovy (semaglutide) | ~$1,349 | From $0–$25/mo* |
| Zepbound (tirzepatide) | ~$1,060 | From $25/mo* |
| Ozempic (semaglutide) | ~$1,035 | From $25/mo* |
| Mounjaro (tirzepatide) | ~$1,070 | From $25/mo* |
| Wegovy pill (oral) | ~$349/mo | Varies |
*Savings card what you pay is for commercially insured patients who meet eligibility criteria. Medicare and Medicaid patients are not eligible for most manufacturer savings cards. Prices are subject to change — always verify current the rates directly with the manufacturer or your pharmacy.
2>How GLP-1 Medications Work
Eli Lilly offers manufacturer savings cards for both This glp-1 (tirzepatide for weight loss) and Mounjaro (tirzepatide for type 2 diabetes). Commercially insured patients with coverage for these medications may pay as little as $25 per month. Eli Lilly also offers a self-pay pricing option for The drug through LillyDirect, making it one of the more accessible brand-name GLP-1 weight loss medications for uninsured patients./p>s.Mounjaro and It contain the same active ingredient — tirzepatide — but are FDA-approved for different indications. Mounjaro is approved for type 2 diabetes; The medication is approved for weight management in adults with obesity or overweight with a related health condition. Lilly offers separate manufacturer savings card programs for each..<
For patients comparing Wegovy and Tirzepatide in 2026, clinical trial data shows tirzepatide (Zepbound) produced greater average weight loss than the active ingredient (Wegovy) in head-to-head studies — though individual results vary and your healthcare provider's recommendation should guide your treatment plan.
.n.
GLP-1 Without Insurance 2026: All Your Options
Getting a GLP-1 medication without insurance in 2026 is possible through several pathways: manufacturer self-pay programs (Wegovy at ~$299/mo via Novo Nordisk, Zepbound via LillyDirect), compounded semaglutide or compounded tirzepatide from licensed 503A compounding pharmacies, telehealth GLP-1 providers, and state Medicaid programs that now cover GLP-1s for weight loss in many states.
Compounded semaglutide — made at licensed compounding pharmacies — was widely available as a cheaper alternative during the Ozempic shortage. The FDA has ended the compounded semaglutide shortage designation, which means compounded versions may no longer be legally available as of 2025 from most compounding pharmacies. Check current FDA guidance before pursuing compounded glp-1 medications — availability has changed significantly.
For many patients, telehealth GLP-1 providers are the most accessible entry point. Platforms like ShedRx connect patients with licensed providers who can prescribe GLP-1 weight loss medications online, often with access to manufacturer savings programs or self-pay pricing options that make starting doses more affordable.
Cheapest GLP-1 Options in 2026
If cost is your primary concern, here's how the cheapest GLP-1 options rank in 2026:
- Compounded tirzepatide or semaglutide — If still legally available from a licensed 503A compounding pharmacy, compounded versions offer the lowest monthly cost, often $150–$400 depending on dose. Verify FDA status before pursuing.
- Zepbound via LillyDirect self-pay — Eli Lilly offers Zepbound starting doses at reduced self-pay pricing through LillyDirect for patients without insurance coverage.
- Wegovy self-pay through Novo Nordisk — Approximately $299/month for eligible self-pay patients through Novo Nordisk's direct program.
- Telehealth GLP-1 provider programs — Platforms like ShedRx often bundle provider visits, prescription access, and pricing support into one monthly fee, which can make starting GLP-1 therapy more affordable than navigating brand pricing alone.
- State Medicaid programs — Many states now provide coverage for weight loss through GLP-1s for qualifying Medicaid beneficiaries. Check your state's Medicaid formulary for current coverage.
GLP-1 Weight Loss Journey: What to Expect
Starting GLP-1 therapy typically begins with low starting doses to minimize side effects — most patients begin at 0.25 mg weekly for Wegovy or the lowest available dose for Zepbound. Doses are gradually increased over months until you reach your maintenance dose or the dose that delivers optimal weight loss for your body weight and health conditions.
Clinical trials show that sustained GLP-1 weight loss medications use produces meaningful reductions in body mass index and body weight — along with improved cardiovascular outcomes and reduced risk of heart disease in certain populations. The FDA-approved glp-1 medications approved for weight loss require a body mass index of 30 or higher, or 27 or higher with at least one weight-related health condition.
Always work with a licensed healthcare provider throughout your weight loss journey on a GLP-1 medication. These are powerful injectable medications — not supplements — and dosing, monitoring, and insurance coverage navigation all require professional guidance.
For more information, visit the FDA semaglutide guidance.
Frequently Asked Questions
What is the cheapest GLP-1 medication in 2026?
The cheapest GLP-1 options in 2026 depend on your insurance status. For commercially insured patients, manufacturer savings cards can reduce Wegovy or Zepbound to $0–$25/month. Without insurance, Zepbound's LillyDirect self-pay and Novo Nordisk's Wegovy self-pay programs offer lower list prices. Telehealth GLP-1 providers like ShedRx often offer bundled pricing that may be more accessible than navigating brand pricing alone.
How do GLP-1 manufacturer savings cards work?
Manufacturer savings cards for GLP-1 medications like Wegovy and Zepbound are offered directly by Novo Nordisk and Eli Lilly to commercially insured patients with qualifying coverage. They reduce your copay — often to $0–$25 per month. These cards cannot be used with Medicare, Medicaid, or other government insurance programs. Eligibility requirements and program terms vary and can change.
What is the difference between Wegovy and Ozempic?
Wegovy and Ozempic both contain semaglutide — the same active ingredient — but are FDA-approved for different uses. Wegovy is approved for chronic weight management in adults with obesity. Ozempic is approved for type 2 diabetes and cardiovascular risk reduction. Wegovy is dosed at higher levels (up to 2.4 mg weekly) specifically for weight loss, while Ozempic's maximum approved dose is lower for diabetes management.
Can I get compounded semaglutide in 2026?
Compounded semaglutide availability has significantly changed since the FDA ended the Ozempic/Wegovy shortage designation in 2025. Most 503A compounding pharmacies can no longer legally make compounded semaglutide for individual patients. 503B outsourcing facilities face different rules. Check current FDA guidance and consult a licensed healthcare provider before pursuing compounded GLP-1 medications.
Is there an oral GLP-1 pill for weight loss?
Yes. The first oral GLP-1 medication for weight loss — orforglipron — received FDA approval in 2025. The Wegovy pill (oral semaglutide) is also now available for weight management. Both represent a significant development for patients who prefer not to self-inject. Pricing and savings programs for these newer oral options are still evolving — ask your healthcare provider for current availability and cost.
Does insurance cover GLP-1 medications for weight loss?
Coverage for weight loss through GLP-1 medications varies significantly by insurance plan. Many commercial insurance plans now cover Wegovy and Zepbound for weight management with prior authorization. Medicare Part D began covering GLP-1 weight loss drugs for certain patients in 2026 through the Medicare GLP-1 Bridge Program. Medicaid coverage varies by state. Always verify your specific plan's formulary before starting therapy.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical or financial advice. GLP-1 medications require a prescription from a licensed healthcare provider. Drug prices and savings program eligibility are subject to change — verify current pricing directly with the manufacturer or your pharmacy. Use RxDiff to compare current prices in your area.
Affiliate Disclosure: This post contains affiliate links to ShedRx, a telehealth GLP-1 provider. If you click a link and make a purchase or sign up, RxDiff may earn a commission at no additional cost to you. We only recommend services we believe provide genuine value to patients. This disclosure is made in accordance with FTC guidelines on endorsements and testimonials.
